Article Details
Retrieved on: 2021-08-21 06:07:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination against placebo.
Article found on: www.expresspharma.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here